Processa Pharmaceuticals Inc (PCSA)
NASDAQ
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -56.981 | -27.87 | -79.863 | -44.228 | -156.333 | -154.397 |
Return on Equity (%) | -77.621 | -37.914 | -93.138 | -47.2 | -166.428 | -178.523 |
Return on Invested Capital (%) | -17.887 | -35.486 | -92.567 | -46.825 | -118.191 | -184.079 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | -0.042 | 1.334 | 1.109 | 0.467 | 0.203 |
Earnings Per Share | N/A | -0.087 | -1.364 | -0.727 | -1.715 | -0.452 |
Cash Per Share | N/A | 0.018 | 1.459 | 1.05 | 0.407 | 0.191 |
Working Capital Per Share | N/A | -0.005 | 1.418 | 1.104 | 0.462 | 0.199 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
EBITDA Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
Free Cash Flow Per Share | N/A | -0.108 | -1.44 | -0.777 | -1.764 | -0.451 |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.5M |
Price to Earnings Ratio | -0.31 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.74 |
Price to Book Ratio | 0.69 |
Dividend Yield | - |
Shares Outstanding | 3.27M |
Average Volume (1 week) | 19.47k |
Average Volume (1 Month) | 27.71k |
52 Week Change | -82.78% |
52 Week High | 17.40 |
52 Week Low | 1.045 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.